The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...
The Metastatic Colorectal Cancer Clinical Trials analysis report delivers important insights into ongoing research of 150+ pipeline Metastatic Colorectal Cancer Drugs, clinical strategies, upcoming ...
Understanding where molecular malfunctions happen in colorectal cancer offers new avenues for treatment.Researchers at ...
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
Most colon cancer deaths are caused by the spread of tumor cells beyond the colon, usually to the liver. In a new study, MIT biologists identified a cellular pathway necessary for colorectal cancer ...
Metastatic colorectal cancer (mCRC) continues to increase among patients 45 and younger. Their longer survival and different ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the Ministry of Health of the Republic of Armenia has granted marketing authorizations for Botvymo® ...
Brain metastases (BM) from colorectal cancer (CRC) are uncommon but clinically consequential. We characterized clinicomolecular features of CRC patients with BM and evaluated the prognostic impact of ...
New research reveals that the transcription factor SOX9 drives colorectal cancer metastasis by directly activating the ...
Hosted on MSN
How colon cancer spreads: Scientists uncover 'identity switch' behind deadly metastasis
New Delhi: One of the greatest mysteries in cancer research has long been why some colorectal tumours remain confined to the intestine while others break away, travel through the bloodstream and ...
By HealthDay Staff HealthDay ReporterTUESDAY, Oct. 6, 2026 (HealthDay News) — Aspirin has drawn considerable interest for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results